Login
Toggle navigation
Videos
Categories
Trending
Dr. Sundar Kamath, Senior VP & CTO of Sanmina Corp, San Jose, CA.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Jure Sola is Chairman and Chief Executive Officer of Sanmina Corp
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Stayble Therapeutics' Andreas Gerward on Capital Raise, New Ownership, and Near-Term Milestones | Andreas Gerward, CEO, Stayble Therapeutic AB.
00:10:00
Dale Tsai, General Manager of the United States|CEO, AOPEN Inc
00:10:00
Embracing the Future: A Journey Towards Innovation and Globalization in Brazilian Companies | Efraim Horn, CEO , Cyrela Brazil Realty SA Empreendimentos e Participacoes.
00:10:00
An analyst discusses Naver and SK Telecom and their strategies.
00:10:00
Building Startups In The Right Now Economy|Mark Siegel,Managing Director,Menlo Ventures
00:10:00
Regulus Resources Showcases Advancements in Peru Copper Project at One-to-One Mining Conference
00:10:00
Brisanet CEO José Roberto Nogueira on Overcoming Challenges and Future Plans | José Roberto Nogueira ,CEO, Brisanet Participações SA.
00:10:00
Understanding Market Dynamics with Blue Owl Capital's Co-Chief Executive Officer | Marc Lipschultz, Co-CEO , Blue Owl Capital.
00:10:00
2024 Global Market Outlook – Q3 Update: Navigating the Three-Scenario Problem
00:10:00
Join Ajay Kochhar, CEO of Li-Cycle, as he explores the innovative field of lithium-ion battery recycling in partnership with Company (ABAT).
00:10:00
Here's a transcript of the interview between Brendan Cahill, CEO of Excellon Resources, and Adam from Assay TV
00:10:00
De Belegger on Tour - Pitch with Francis Van Eeckhout, CEO Deceuninck | Francis Van Eeckhout - CEO of Deceuninck